APO-IRBESARTAN HCTZ 300/25 irbesartan and hydrochlorothiazide 300/25mg tablet blister pack Australia - engelsk - Department of Health (Therapeutic Goods Administration)

apo-irbesartan hctz 300/25 irbesartan and hydrochlorothiazide 300/25mg tablet blister pack

arrotex pharmaceuticals pty ltd - irbesartan, quantity: 300 mg; hydrochlorothiazide, quantity: 25 mg - tablet, film coated - excipient ingredients: lactose monohydrate; povidone; croscarmellose sodium; magnesium stearate; iron oxide yellow; iron oxide red; titanium dioxide; hypromellose; macrogol 4000; iron oxide black - for the treatment of hypertension. treatment should not be initiated with this fixed-dose combination.

APO-IRBESARTAN HCTZ 300/12.5 irbesartan and hydrochlorothiazide 300/12.5mg tablet blister pack Australia - engelsk - Department of Health (Therapeutic Goods Administration)

apo-irbesartan hctz 300/12.5 irbesartan and hydrochlorothiazide 300/12.5mg tablet blister pack

arrotex pharmaceuticals pty ltd - irbesartan, quantity: 300 mg; hydrochlorothiazide, quantity: 12.5 mg - tablet, film coated - excipient ingredients: lactose monohydrate; povidone; magnesium stearate; croscarmellose sodium; iron oxide yellow; iron oxide red; titanium dioxide; hypromellose; macrogol 4000 - for the treatment of hypertension. treatment should not be initiated with this fixed-dose combination.

APO-IRBESARTAN HCTZ 150/12.5 irbesartan and hydrochlorothiazide 150/12.5mg tablet blister pack Australia - engelsk - Department of Health (Therapeutic Goods Administration)

apo-irbesartan hctz 150/12.5 irbesartan and hydrochlorothiazide 150/12.5mg tablet blister pack

arrotex pharmaceuticals pty ltd - irbesartan, quantity: 150 mg; hydrochlorothiazide, quantity: 12.5 mg - tablet, film coated - excipient ingredients: magnesium stearate; povidone; lactose monohydrate; croscarmellose sodium; iron oxide yellow; iron oxide red; titanium dioxide; hypromellose; macrogol 4000 - for the treatment of hypertension. treatment should not be initiated with this fixed-dose combination.

APO-IRBESARTAN irbesartan 75mg film-coated tablet blister pack Australia - engelsk - Department of Health (Therapeutic Goods Administration)

apo-irbesartan irbesartan 75mg film-coated tablet blister pack

arrotex pharmaceuticals pty ltd - irbesartan, quantity: 75 mg - tablet, film coated - excipient ingredients: lactose monohydrate; croscarmellose sodium; povidone; magnesium stearate; titanium dioxide; hypromellose; macrogol 4000 - irbesartan is indicated for the following: for the treatment of hypertension. for delaying the progression of renal disease in hypertensive type ii diabetics with persistent micro-albuminuria (equal to or greater than 30 mg per 24 hours) or urinary protein in excess of 900 mg per 24 hours.

APO-IRBESARTAN irbesartan 300mg film-coated tablet blister pack Australia - engelsk - Department of Health (Therapeutic Goods Administration)

apo-irbesartan irbesartan 300mg film-coated tablet blister pack

arrotex pharmaceuticals pty ltd - irbesartan, quantity: 300 mg - tablet, film coated - excipient ingredients: croscarmellose sodium; lactose monohydrate; magnesium stearate; povidone; titanium dioxide; hypromellose; macrogol 4000 - irbesartan is indicated for the following: for the treatment of hypertension. for delaying the progression of renal disease in hypertensive type ii diabetics with persistent micro-albuminuria (equal to or greater than 30 mg per 24 hours) or urinary protein in excess of 900 mg per 24 hours.

APO-IRBESARTAN irbesartan 150mg film-coated tablet blister pack Australia - engelsk - Department of Health (Therapeutic Goods Administration)

apo-irbesartan irbesartan 150mg film-coated tablet blister pack

arrotex pharmaceuticals pty ltd - irbesartan, quantity: 150 mg - tablet, film coated - excipient ingredients: lactose monohydrate; povidone; croscarmellose sodium; magnesium stearate; titanium dioxide; hypromellose; macrogol 4000 - irbesartan is indicated for the following: for the treatment of hypertension. for delaying the progression of renal disease in hypertensive type ii diabetics with persistent micro-albuminuria (equal to or greater than 30 mg per 24 hours) or urinary protein in excess of 900 mg per 24 hours.

Irbesartan + Hidroclorotiazida Pharmakern 150 mg + 12.5 mg Comprimido revestido por película Portugal - portugisisk - INFARMED (Autoridade Nacional do Medicamento e Produtos de Saúde)

irbesartan + hidroclorotiazida pharmakern 150 mg + 12.5 mg comprimido revestido por película

pharmakern portugal - produtos farmacêuticos, sociedade unipessoal, lda. - irbesartan + hidroclorotiazida - comprimido revestido por película - 150 mg + 12.5 mg - irbesartan 150 mg ; hidroclorotiazida 12.5 mg - irbesartan and diuretics - genérico - duração do tratamento: longa duração

Irbesartan + Hidroclorotiazida Pharmakern 150 mg + 12.5 mg Comprimido revestido por película Portugal - portugisisk - INFARMED (Autoridade Nacional do Medicamento e Produtos de Saúde)

irbesartan + hidroclorotiazida pharmakern 150 mg + 12.5 mg comprimido revestido por película

pharmakern portugal - produtos farmacêuticos, sociedade unipessoal, lda. - irbesartan + hidroclorotiazida - comprimido revestido por película - 150 mg + 12.5 mg - irbesartan 150 mg ; hidroclorotiazida 12.5 mg - irbesartan and diuretics - genérico - duração do tratamento: longa duração

Irbesartan + Hidroclorotiazida Pharmakern 150 mg + 12.5 mg Comprimido revestido por película Portugal - portugisisk - INFARMED (Autoridade Nacional do Medicamento e Produtos de Saúde)

irbesartan + hidroclorotiazida pharmakern 150 mg + 12.5 mg comprimido revestido por película

pharmakern portugal - produtos farmacêuticos, sociedade unipessoal, lda. - irbesartan + hidroclorotiazida - comprimido revestido por película - 150 mg + 12.5 mg - irbesartan 150 mg ; hidroclorotiazida 12.5 mg - irbesartan and diuretics - genérico - duração do tratamento: longa duração

Irbesartan + Hidroclorotiazida Basi 150 mg + 12.5 mg Comprimido Portugal - portugisisk - INFARMED (Autoridade Nacional do Medicamento e Produtos de Saúde)

irbesartan + hidroclorotiazida basi 150 mg + 12.5 mg comprimido

laboratórios basi - indústria farmacêutica, s.a - irbesartan + hidroclorotiazida - comprimido - 150 mg + 12.5 mg - irbesartan 150 mg ; hidroclorotiazida 12.5 mg - irbesartan and diuretics - genérico - duração do tratamento: longa duração